<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03426306</url>
  </required_header>
  <id_info>
    <org_study_id>17-2216.cc</org_study_id>
    <nct_id>NCT03426306</nct_id>
  </id_info>
  <brief_title>A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)</brief_title>
  <official_title>A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the correlation between pre-surgical 4DCT-ventilation imaging and post-surgical&#xD;
      lung function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the correlation between pre-surgical 4-Dimensional Computed&#xD;
      Tomography-ventilation (4DCT-ventilation) imaging and post-surgical lung function. To&#xD;
      determine whether 4DCT-ventilation is a better predictor of post-surgical lung function than&#xD;
      nuclear medicine imaging using pulmonary function tests (PFTs). To determine whether&#xD;
      4DCT-ventilation is a better predictor of post-surgical lung function than nuclear medicine&#xD;
      imaging using quality of life (QOL) questionnaires. Evaluate cost-effectiveness of using&#xD;
      4DCT-ventialtion and VQ scans for pre-surgical assessment. To use longitudinal (pre and&#xD;
      post-surgical) 4DCT-ventilation imaging to derive novel post-surgical prediction formulas.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 21, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pre-Surgical Imaging and Post-Surgical Lung Function</measure>
    <time_frame>Baseline visit to follow up visit, up to 9 months.</time_frame>
    <description>Measure the correlation between pre-surgical 4-Dimensional Computed Tomography-ventilation (4DCT) imaging and post surgical lung function using a Percent Predicted Post-Operative Pulmonary Function Test (%PPO PFT).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ability of %PPO PFTs</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Use %PPO PFTs to determine if 4DCT-ventilation is a better predictor of post surgical lung function than nuclear medicine imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QOL)</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Use QOL questionnaires to determine if 4DCT-ventilation is a better predictor of post surgical lung function than nuclear medicine imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-Effectiveness</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Determine the cost-effectiveness of 4DCT-ventialtion and VQ scans for pre-surgical assessment using Receiver Operator Characteristic (ROC) analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal Imaging Changes</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Derive novel post-surgical prediction formulas using longitudinal 4DCT-ventilation imaging</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>4DCT-ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient will undergo 4DCT imaging. The 4DCT imaging data along with image processing techniques will be used to generate a 4DCT-ventilation map. All surgical decisions will be based on the current standard of care imaging (VQ scans) and not on the 4DCT imaging results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>4DCT-Ventilation</intervention_name>
    <description>4DCT-ventilation is an imaging modality that provides superior image quality, reduced cost, and a faster imaging procedure compared to nuclear medicine VQ scans.</description>
    <arm_group_label>4DCT-ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Provision to sign and date the consent form.&#xD;
&#xD;
          2. Stated willingness to comply with all required (non-optional) study procedures and be&#xD;
             available for the duration of the study.&#xD;
&#xD;
          3. Be a male or female aged 18 to 100.&#xD;
&#xD;
          4. Patient with lung cancer (presumed or biopsy proven) currently undergoing or having&#xD;
             undergone evaluation for resection.&#xD;
&#xD;
          5. Lung function assessment required for pre-surgical evaluation at the discretion of the&#xD;
             cardiothoracic surgeon.&#xD;
&#xD;
          6. Life expectancy greater than 3 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Patients getting a planned wedge resection as the only thoracic resectional procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Jones</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robyn Swing</last_name>
    <phone>720-848-0607</phone>
    <email>Robyn.swing@ucdenver.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robyn Swing</last_name>
      <phone>720-848-0607</phone>
      <email>robyn.swing@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Bernard Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCHealth Memorial Hospital</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Valdez</last_name>
      <phone>719-365-2406</phone>
      <email>angie.valdez@uchealth.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Blum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>February 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2018</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>4-Dimensional Computed Tomography</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

